Home / FlashMed


Titolo Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics
Autore Sunil V. Badve,*† Deborah L. Zimmerman,*† Greg A. Knoll, *†± Kevin D. Burns,*† and Brendan B. McCormick*† - *Division of Nephrology, Department of Medicine, University of Ottawa and The Ottawa Hospital Ottawa, Canada, †Kidney Research Centre and ±The Clinical Epidemiology Program, Ottawa Health Research Institute, Ottawa, Canada
Referenza Clin J Am Soc Nephrol 2008; 3: 1711-1717 doi: 10.2215/CJN.00190108
Contenuto Background and objectives: Hyperphosphatemia is an independent risk factor for mortality in ESRD, but factors regulating phosphate clearance on peritoneal dialysis (PD) are incompletely understood. The objective of this study was to test the hypothesis that peritoneal phosphate clearance is better with continuous ambulatory PD (CAPD) as compared with continuous cyclic PD (CCPD) after adjusting for membrane transport status. Design, setting, participants, & measurements: In this cross-sectional and retrospective study, measurements of peritoneal phosphate clearance of 129 prevalent PD patients were reviewed. Patients were divided according to membrane transport status (high, high average, low average-low categories) and PD modality (CAPD or CCPD). Results: Among high transporters, peritoneal phosphate clearances were comparable in both modalities. However, treatment with CAPD was associated with increased peritoneal phosphate clearance compared with CCPD among high-average transporters (42.4 _ 11.4 versus 36.4 _ 8.3 L/wk/1.73 m2, P _ 0.01), and low-average-low transporters (35.6 _ 5.9 versus 28.9 _ 11 L/wk/1.73 m2, P _ 0.034). On multivariate linear regression, PD modality, membrane transport category, and peritoneal creatinine clearance, but not Kt/V urea, were independently associated with peritoneal phosphate clearance. Conclusions: Peritoneal phosphate clearance is determined by PD modality and membrane transport category, suggesting that PD regimes with longer dwell times may help control hyperphosphatemia in lower transporters.
Data 19.11.2008
Maggiori informazioni   
Lista completa